Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

Barbara Pro, Steven M. Horwitz, H. Miles Prince, Francine M. Foss, Lubomir Sokol, Matthew Greenwood, Dolores Caballero, Franck Morschhauser, Martin Wilhelm, Swaminathan Padmanabhan Iyer, Andrei R. Shustov, Julie Wolfson, Barbara E. Balser, Bertrand Coiffier

Research output: Contribution to journalLetter

12 Scopus citations
Original languageEnglish (US)
Pages (from-to)914-917
Number of pages4
JournalHematological Oncology
Volume35
Issue number4
DOIs
StatePublished - Dec 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Pro, B., Horwitz, S. M., Prince, H. M., Foss, F. M., Sokol, L., Greenwood, M., Caballero, D., Morschhauser, F., Wilhelm, M., Iyer, S. P., Shustov, A. R., Wolfson, J., Balser, B. E., & Coiffier, B. (2017). Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma. Hematological Oncology, 35(4), 914-917. https://doi.org/10.1002/hon.2320